Health Care Technology
Company Overview of Seryx Inc.
Seryx Inc. offers drug response interpretation service. The company develops Signature Genetics interpretation and reporting software which provides a summary of the relevant research findings that pertain specifically to a patient's drug regimen and genotype for key drug metabolizing enzymes. Seryx Inc. was founded in 2000 and is based in Montreal, Canada.
353 St Nicolas Street
Montreal, QC H2Y 2P1
Founded in 2000
Key Executives for Seryx Inc.
Seryx Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|3D Bolus Inc.||Americas|
|999 E-Tech Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Seryx Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.